AVANIR PHARMACEUTICALS CL A
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS CL A COM, CUSIP 05348p401.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for AVANIR PHARMACEUTICALS CL A COM, CUSIP 05348p401.